Lamotrigine in the treatment of bipolar depression

European Neuropsychopharmacology

Volumn 9, Issue SUPPL. 4, 1999, Pages

  Bowden, C L ^a   Mitchell, P ^b   Suppes, T ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bipolar depression; Efficacy; Lamotrigine; Placebo controlled trial; Tolerability

Indexed keywords

GABAPENTIN; LAMOTRIGINE; PLACEBO;

BIPOLAR DEPRESSION; CONFERENCE PAPER; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; AFFECT; AMINES; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; RANDOMIZED CONTROLLED TRIALS; TRIAZINES;

EID: 0032781865     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00024-3     Document Type: Conference Paper

References (18)

1. Bowden C.L. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology. 19:1998;194-199.
2. Bowden C.L., Calabrese J.R., McElroy S.L., Rhodes L.J., Keck P.E. Jr., Cookson J. Anderson, J., Bolden-Watson, C. Ascher, J., Monaghan, E., Zhou, O., The efficacy of patients with bipolar disorders. Biol. Psychiatry. 45:1999;953-958.
3. Calabrese J.R., Fatemi S.H., Woyshville M.J. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder (letter). Am. J. Psychiatry. 153:(9):1996;1236.
4. ® monotherapy in the treatment of bipolar disorder. Eur. Neuropsychopharm. 7:1997;S177. (Abstract P.1.133).
5. Calabrese, J., Bowden, C., McElroy, S., Cookson, J., Andersen, J., Keck, P., Rhodes, L., Bolden-Watson, C., Zhou, J., Ascher, J., 1999a. Spectrum of activity of lamotrigine in treatment refractory bipolar disorder. Am. J. Psychiatry (in press).
6. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., Rudd G.D. For the Lamictal 602 Study Group; A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatry. 60:1999;79-88.
7. Fatemi S.H., Rapport D.J., Calabrese J.R., Thuras P. Lamotrigine in rapid-cycling bipolar disorder. J. Clin. Psychiatry. 58:1997;522-527.
8. Fogelson D.L., Sternbach H. Lamotrigine treatment of refractory bipolar disorder (letter). J. Clin. Psychiatry. 58:1997;271-273.
9. Frye M. Gabapentin and lamotrigine monotherapy in mood disorder: an update. Syllabus and Proceedings Summary of the American Psychiatric Association meeting, Toronto, Canada, May 30-June 4 :1998;150.
10. Gilman J.T. Lamotrigine: an antiepileptic agent for the treatment of partial seizures. Ann. Pharmacother. 29:1995;144-151.
11. Kotler M., Matar M.A. Lamotrigine in the treatment of resistant bipolar disorder. Clin. Neuropharmacol. 21:1998;65-67.
12. Kusumakar V., Yatham L.N. Lamotrigine treatment of rapid cycling bipolar disorder (letter). Am. J. Psychiatry. 154:1997;1171-1172.
13. Kusumakar V., Yatham L.N. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 72:1997;145-148.
14. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry. 164:1994;549-550.
15. Smith D., Baker G., Davies G., Dewey M., Chadwick G.W. Outcomes of add-on treatment with lamotrigine treatment in partial epilepsy. Epilepsia. 34:1993;312-322.
16. Sporn J., Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J. Clin. Psychopharmacol. 17:1997;185-189.
17. Suppes T., Sherwood Brown E., McElroy S.L., Keck P.E., Nolen W., Kupka R., Frye M., Denicoff K.D., Altshuler L., Leverich G.S., Post R.M. Lamotrigine for the Treatment of Bipolar Disorder: A Clinical Case Series. J. Affect. Disord. 53:1999;95-98.
18. Yatham L.N., Kusumakar V., Parikh S.V., Haslam D.R.S., Matte R., Sharma V., Kennedy S. Bipolar depression: treatment options. Can. J. Psychiatry. 42:(Suppl. 2):1997;87S-91S.